Suppr超能文献

作为广谱β-内酰胺酶抑制剂的含6,5-双环杂环的6-亚甲基青霉烯类化合物的构效关系:通过计算方法证明具有C7 R立体化学的1,4-硫氮杂环庚烷中间体

Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum beta-lactamase inhibitors: evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods.

作者信息

Venkatesan Aranapakam M, Agarwal Atul, Abe Takao, Ushirogochi Hideki, Yamamura Itsuka, Ado Mihira, Tsuyoshi Takasaki, Dos Santos Osvaldo, Gu Yansong, Sum Fuk-Wah, Li Zhong, Francisco Gerry, Lin Yang-I, Petersen Peter J, Yang Youjun, Kumagai Toshio, Weiss William J, Shlaes David M, Knox James R, Mansour Tarek S

机构信息

Wyeth Research, Chemical and Screening Sciences, Department of Infectious Disease and Biological Technologies, 401 N. Middletown Road, Pearl River, New York 10965, USA.

出版信息

J Med Chem. 2006 Jul 27;49(15):4623-37. doi: 10.1021/jm060021p.

Abstract

The design and synthesis of a series of 6-methylidene penems containing [6,5]-fused bicycles (thiophene, imidazole, or pyrazle-fused system) as novel class A, B, and C beta-lactamase inhibitors is described. These penems proved to be potent inhibitors of the TEM-1 (class A) and AmpC (class C) beta-lactamases and less so against the class B metallo-beta-lactamase CcrA. Their in vitro and in vivo activities in combination with piperacillin are discussed. On the basis of the crystallographic structures of a serine-bound reaction intermediate of 2 with SHV-1 (class A) and GC1 (class C) enzymes, compounds 14a-l were designed and synthesized. Penems are proposed to form a seven-membered 1,4 thiazepine ring in both class A and C beta-lactamases. The interaction energy calculation for the enzyme-bound intermediates favor the formation of the C7 R enantiomer over the S enantiomer of the 1,4-thiazepine in both beta-lactamases, which is consistent with those obtained from the crystal structure of 2 with SHV-1 and GC1.

摘要

描述了一系列含有[6,5]稠合双环(噻吩、咪唑或吡唑稠合体系)的6-亚甲基青霉烯类化合物的设计与合成,这些化合物作为新型的A、B和C类β-内酰胺酶抑制剂。这些青霉烯类化合物被证明是TEM-1(A类)和AmpC(C类)β-内酰胺酶的有效抑制剂,而对B类金属β-内酰胺酶CcrA的抑制作用较弱。讨论了它们与哌拉西林联合使用时的体外和体内活性。基于化合物2与SHV-1(A类)和GC1(C类)酶的丝氨酸结合反应中间体的晶体结构,设计并合成了化合物14a-l。青霉烯类化合物被认为在A类和C类β-内酰胺酶中均形成七元1,4-噻氮杂环。对酶结合中间体的相互作用能计算表明,在两种β-内酰胺酶中,1,4-噻氮杂环的C7 R对映体比S对映体更有利于形成,这与化合物2与SHV-1和GC1的晶体结构结果一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验